Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Research gaps in psoriasis: opportunities for future studies.

Ryan C, Korman NJ, Gelfand JM, Lim HW, Elmets CA, Feldman SR, Gottlieb AB, Koo JY, Lebwohl M, Leonardi CL, Van Voorhees AS, Bhushan R, Menter A.

J Am Acad Dermatol. 2014 Jan;70(1):146-67. doi: 10.1016/j.jaad.2013.08.042. Epub 2013 Oct 11. Review.

PMID:
24126079
2.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

American Academy of Dermatology Work Group, Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Leonardi CL, Lim HW, Van Voorhees AS, Beutner KR, Ryan C, Bhushan R.

J Am Acad Dermatol. 2011 Jul;65(1):137-74. doi: 10.1016/j.jaad.2010.11.055. Epub 2011 Feb 8. Review.

PMID:
21306785
3.

From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.

Hugh J, Van Voorhees AS, Nijhawan RI, Bagel J, Lebwohl M, Blauvelt A, Hsu S, Weinberg JM.

J Am Acad Dermatol. 2014 Jan;70(1):168-77. doi: 10.1016/j.jaad.2013.09.020. Epub 2013 Nov 1. Review.

PMID:
24184141
4.

Psoriasis: comorbidities and associations.

Farley E, Menter A.

G Ital Dermatol Venereol. 2011 Feb;146(1):9-15. Review.

PMID:
21317853
5.

Psoriasis and its comorbidities.

Onumah N, Kircik LH.

J Drugs Dermatol. 2012 May;11(5 Suppl):s5-10. Review.

PMID:
22644770
6.

Psoriasis: a skin disease associated with increased cardiovascular risk.

González-Gay MA, González-Vela C, González-Juanatey C.

Actas Dermosifiliogr. 2012 Sep;103(7):595-8. Epub 2012 Mar 31. Review. English, Spanish.

PMID:
22465257
7.

Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Mease PJ, Boehncke WH, Gladman DD.

J Rheumatol. 2013 Aug;40(8):1407-9. doi: 10.3899/jrheum.130450.

PMID:
23908533
8.

Metabolic comorbidities and psoriasis.

Gisondi P, Ferrazzi A, Girolomoni G.

Acta Dermatovenerol Croat. 2010;18(4):297-304. Review.

PMID:
21251450
9.

Psoriasis and cardiovascular disorders.

Ryan C, Menter A.

G Ital Dermatol Venereol. 2012 Apr;147(2):179-87. Review.

PMID:
22481581
10.

Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.

Armstrong AW, Gelfand JM, Boehncke WH, Armstrong EJ.

J Rheumatol. 2013 Aug;40(8):1434-7. doi: 10.3899/jrheum.130457.

PMID:
23908540
11.

Severity and management of psoriasis within primary care.

Wade AG, Crawford GM, Young D, Leman J, Pumford N.

BMC Fam Pract. 2016 Oct 14;17(1):145.

12.

Comorbidities in Psoriatic Arthritis.

Husni ME.

Rheum Dis Clin North Am. 2015 Nov;41(4):677-98. doi: 10.1016/j.rdc.2015.07.008. Epub 2015 Sep 5. Review.

PMID:
26476226
13.

Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.

Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1729-35. doi: 10.1002/acr.20627.

14.

Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.

Driessen RJ, Boezeman JB, Van De Kerkhof PC, De Jong EM.

J Dermatolog Treat. 2009;20(1):42-7. doi: 10.1080/09546630802225702.

PMID:
18649164
15.

Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.

Ryan C, Kirby B.

Dermatol Clin. 2015 Jan;33(1):41-55. doi: 10.1016/j.det.2014.09.004. Review.

PMID:
25412782
16.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Tobin AM, Kirby B.

BioDrugs. 2005;19(1):47-57. Review.

PMID:
15691217
17.

[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].

Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo JL; Grupo de Trabajo en Comorbilidades asociadas a la Psoriasis.

Actas Dermosifiliogr. 2012 Jan;103 Suppl 1:1-64. doi: 10.1016/S0001-7310(12)70001-7. Spanish.

PMID:
22364603
18.

Can early treatment with biologicals modify the natural history of comorbidities?

Vena GA, Vestita M, Cassano N.

Dermatol Ther. 2010 Mar-Apr;23(2):181-93. doi: 10.1111/j.1529-8019.2010.01313.x. Review.

PMID:
20415826
19.

[Comorbidity in psoriasis].

Gerdes S, Mrowietz U, Boehncke WH.

Hautarzt. 2016 Jun;67(6):438-44. doi: 10.1007/s00105-016-3805-3. Review. German.

PMID:
27221798
20.

Comorbidities significantly impact patients' preferences for psoriasis treatments.

Schmieder A, Schaarschmidt ML, Umar N, Terris DD, Goebeler M, Goerdt S, Peitsch WK.

J Am Acad Dermatol. 2012 Sep;67(3):363-72. doi: 10.1016/j.jaad.2011.08.023. Epub 2011 Oct 19.

PMID:
22015150

Supplemental Content

Support Center